Fewer adults with lung cancer who underwent photon-counting vs. conventional CT had an adverse reaction, according to data ...
Vergent Bioscience, a clinical-stage biotechnology company advancing molecularly targeted intraoperative imaging, today announced the initiation of VISUALIZE 2, a Phase 3, multi-center, pivotal study ...
Gen-AI is increasingly recognized for its potential in healthcare, particularly in complex radiological interpretations. However, the clinical utility of Gen-AI requires thorough validation with ...
First lifetime payer-perspective economic analysis of AI-assisted risk stratification for indeterminate pulmonary nodules (IPN). Led by researchers at the Vanderbilt University Medical Center, a new ...
(Nasdaq: BDSX), a leading diagnostics solutions company, announced the publication of the largest lung nodule biomarker clinical validation study ever conducted. This milestone strengthens the ...
UAB Hospital and The Kirklin Clinic have a multidisciplinary team of physicians directing the evaluation and management of lung cancer and other neoplasms with chest involvement. State of the art ...
Severe COVID-19 and influenza infections can epigenetically reprogram lung and immune cells, creating a pro‑tumor environment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results